ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Maxpro Capital Acquisition Corporation

Maxpro Capital Acquisition Corporation (JMAC)

10,81
0,00
(0,00%)
Fermé 10 Novembre 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
10,81
Prix Achat
10,80
Prix Vente
12,05
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
10,81
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

JMAC Dernières nouvelles

Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq

FOSTER CITY, Calif., March 30, 2023 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates...

Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business Combination

Taipei City, Jan. 13, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) (the “Company”) announced today that its sponsor, MP One Investment LLC (the...

Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business Combination

TAIPEI CITY, Jan. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) (the “Company”), announced today that its sponsor, MP One Investment LLC (the...

Apollomics Inc. Receives FDA Orphan Drug Designation for Vebreltinib (APL-101) for Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor Aberrations

FOSTER CITY, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: JMAC), an innovative biopharmaceutical company committed to the discovery and development of mono- and...

Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business Combination

TAIPEI CITY, Oct. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) (the “Company”) announced today that its sponsor, MP One Investment LLC (the...

Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business Combination

Taipei City, Oct. 07, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) (the “Company”), announced today that its sponsor, MP One Investment LLC (the...

Apollomics Inc., a Late-Stage Clinical Biopharmaceutical Company to be Listed on Nasdaq Through Business Combination with Maxpro Capital Acquisition Corp.

– Transaction values Apollomics at pre-money equity value of $899 million– Apollomics is a late-stage clinical biopharmaceutical company developing innovative product candidates for large, unmet...

Maxpro Capital Acquisition Corp. Announces the Separate Trading of Its Class A Common Stock and Warrants

TAIPEI CITY, Nov. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Maxpro Capital Acquisition Corp. (“Maxpro” or the “Company”), a blank check company formed for the purpose of effecting a...

Maxpro Capital Acquisition Corp. Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option

Taipei City, Oct. 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maxpro Capital Acquisition Corp. (the “Company”), a Taiwan based SPAC, today announced the closing of its initial public...

Maxpro Capital Acquisition Corp. Announces Pricing of $90,000,000 Initial Public Offering

Taipei City, Oct. 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maxpro Capital Acquisition Corp. (the “Company”), a Taiwan based SPAC, announced today that it priced its initial public...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
INODInnodata Inc
US$ 42,75
(75,64%)
9,61M
SEZLSezzle Inc
US$ 428,58
(71,11%)
632,22k
SONDSonder Holdings Inc
US$ 4,36
(60,89%)
1,42M
INDIindie Semiconductor Inc
US$ 5,50
(60,35%)
36,22M
AZIAutozi Internet Technology Global Ltd
US$ 2,54
(55,83%)
13,41M
PRPHProPhase Labs Inc
US$ 0,78
(-45,45%)
2,65M
ELWSEarlyworks Co Ltd
US$ 3,69
(-45,33%)
854,2k
ALVRAlloVir Inc
US$ 0,6103
(-37,82%)
2,05M
CHSNChanson International Holding
US$ 5,66
(-37,60%)
529,66k
RVNCRevance Therapeutics Inc
US$ 3,705
(-35,90%)
12,98M
ELABElevai Labs Inc
US$ 0,0188
(5,03%)
438,79M
TIVCTivic Health Systems Inc
US$ 0,4003
(53,67%)
292,84M
TSLATesla Inc
US$ 321,22
(8,19%)
205,04M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 19,06
(16,29%)
188,36M
NVDANVIDIA Corporation
US$ 147,63
(-0,84%)
176,85M
Aucune Discussion Trouvée
Ajouter une Discussion